Advanced Medical Solutions Group (LSE:AMS) says it is in discussions with TA Associates (UK) LLP regarding "a possible offer for the entire issued and to be issued share capital of AMS." AMS said.
There can be no certainty that a firm offer will be made, nor as to the terms on which a firm offer might be made, the company added.
Under the City Code timetable cited in the announcement, TA must either announce a firm intention to bid or confirm it will not do so by 5.00pm on 16 May; that deadline may be extended with the Takeover Panel's consent.
AMS describes itself in the filing as a global developer and manufacturer of tissue‑healing technology with more than 1,600 employees and manufacturing in multiple countries.
"A further announcement will be made as and when appropriate," AMS said.
